Cargando…
High expression levels of the D686N Parkinson's disease mutation in VPS35 induces α-synuclein-dependent toxicity in yeast
Parkinson's disease (PD) is a common neurodegenerative disorder that affects ~2% of the human population aged >65. α-synuclein serves a role in the pathogenesis of PD as it is a primary component of Lewy bodies, a pathological feature of PD. Endosomal-lysosomal dysfunction may be a key facto...
Autores principales: | Huang, Yi, Chen, Xiang, He, Xiaofei, Guo, Caifeng, Sun, Xicui, Liang, Fengyin, Long, Simei, Lu, Xilin, Feng, Luyang, Guo, Wenyuan, Zeng, Yixuan, Pei, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482071/ https://www.ncbi.nlm.nih.gov/pubmed/28487947 http://dx.doi.org/10.3892/mmr.2017.6551 |
Ejemplares similares
-
VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson’s disease
por: Chen, Xi, et al.
Publicado: (2023) -
Screening for VPS35 mutations in Parkinson's disease
por: Sheerin, Una-Marie, et al.
Publicado: (2012) -
VPS35, the Retromer Complex and Parkinson’s Disease
por: Williams, Erin T., et al.
Publicado: (2017) -
Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington’s disease
por: Zeng, Yixuan, et al.
Publicado: (2016) -
Commentary: Parkinson's Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein
por: Olszewska, Diana A., et al.
Publicado: (2016)